Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide

Transfusion

Volumn 44, Issue 5, 2004, Pages 785-789

  Abrahamsen, Jenny Foss ^a   Rusten, Leiv ^b   Bakken, Anne M ^b   Bruserud, Øystein ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; DIMETHYL SULFOXIDE; LIQUID NITROGEN;

ADOLESCENT; ADULT; ARTICLE; AUTOTRANSPLANTATION; BLOOD STORAGE; CANCER PATIENT; CELL CULTURE; CELL SURVIVAL; CELL VIABILITY; CLINICAL ARTICLE; CLONOGENIC ASSAY; COLONY FORMING CELL; CRYOPRESERVATION; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LONG TERM CARE; MALE; PERIPHERAL BLOOD STEM CELL;

ADOLESCENT; ADULT; AGED; BLOOD PRESERVATION; CRYOPRESERVATION; DIMETHYL SULFOXIDE; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED;

EID: 2342548178     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.03336.x     Document Type: Article

References (21)

1. Goldman JM, Th'ng KH, Park DS, et al. Collection, cryopreservation and subsequent viability of haemopoietic stem cells intended for treatment of chronic granulocytic leukaemia in blast-cell transformation. Br J Haematol 1978;40:185-95.
2. Davis JM, Rowley SD, Braine HG, et al. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990;75:781-6.
3. Stroncek DF, Fautsch SK, Lasky LC, et al. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991;31:521-6.
4. Zambelli A, Poggi G, Da Prada G, et al. Clinical toxicity of cryopreserved circulating progenitor cell infusion. Anticancer Res 1998;18:4705-8.
5. Lakota J, Fuchsberger P. Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO. Bone Marrow Transplant 1996;18:262-3.
6. Katayama Y, Yano T, Bessho A, et al. The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells. Bone Marrow Transplant 1997;19:283-7.
7. Halle P, Tournilhac O, Knopinska-Posluszny W, et al. Uncontrolled-rate freezing and storage at -80°C, with only 3.5 percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion 2001;41:667-73.
8. Donaldson C, Armitage WJ, Denning-Kendall PA, et al. Optimal cryopreservation of human umbilical cord blood. Bone Marrow Transplant 1996;18:725-31.
9. Abrahamsen JF, Bakken AM, Bruserud O. Cryopreserving human peripheral blood progenitor cells with 5 percent rather than 10 percent DMSO results in less apoptosis and necrosis in CD34+ cells. Transfusion 2002;42:1573-80.
10. Bakken AM, Bruserud O, Abrahamsen JF. No difference in colon¥ colony formation of peripheral blood stem cells frozen with 5% or 10% dimethyl sulfoxide. J Hematother Stem Cell Res 2003;12:351-8.
11. Galmes A, Besalduch I, Bargay J, et al. Long-term storage at -80°C of hematopoietic progenitor cells with 5 percent dimethyl sulfoxide as the sole cryoprotectant. Transfusion 1999;39:70-3.
12. Verfaillie CM. Can human hematopoietic stem cells be cultured ex vivo? Stem Cells 1994;12:466-76.
13. Sutherland HJ, Eaves CJ, Eaves AC, et al. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 1989;74:1563-70.
14. Sutherland HJ, Lansdorp PM, Henkelman DH, et al. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci U S A 1990;87:3584-8.
15. Hao QL, Thiemann FT, Petersen D, et al. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood 1996;88:3306-13.
16. Balint B, Ivanovic Z, Petakov M, et al. The cryopreservation protocol optimal for progenitor recovery is not optimal for preservation of marrow repopulating ability. Bone Marrow Transplant 1999;23:613-9.
17. Rusten LS, Jacobsen SE, Kaalhus O, et al. Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells. Blood 1994;84:1473-81.
18. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 1989;86:3828-32.
19. Dybedal I, Yang L, Bryder D, et al. Human reconstituting hematopoietic stem cells up-regulate Fas expression upon active cell cycling but remain resistant to Fas-induced suppression. Blood 2003;102:118-26.
20. Keeney M, Chin-Yee I, Weir K, et al. Single platform flow cytometric: absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry 1998;34:61-70.
21. Kasper C, Ryder WD, Durig J, et al. Content of long-term culture-initiating cells, clonogenic progenitors and CD34 cells in apheresis harvests of normal donors for allogeneic transplantation, and in patients with acute myeloid leukaemia or multiple myeloma. Br J Haematol 1999;104:374-81.